How to buy Marizyme stock (Marizyme)

Marizyme is a biotechnology business based in the US. Marizyme shares (MRZM) are listed on the OTCQB and all prices are listed in US Dollars. Its last market close was $0.01 – a decrease of 50% over the previous week.

Our top picks for where to buy Marizyme stock

Buy Marizyme stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Marizyme stock price (OTCQB: MRZM)

Use our graph to track the performance of MRZM stocks over time.

Marizyme shares at a glance

• Key figures

Information last updated 2024-12-26.

Latest market close	$0.01
52-week range	$0.02 - $0.13
50-day moving average more info button	$0.04
200-day moving average more info button	$0.06
Wall St. target price	N/A
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.97

Is it a good time to buy Marizyme stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Marizyme price performance over time

Historical closes compared with the close of $0.02 from 2024-12-26

1 week (2024-12-20)	0.02
1 month (2024-11-27)	-60.00%
3 months (2024-09-27)	-60.00%
6 months (2024-06-28)	-60.00%

1 year (2023-12-28)	-80.00%
2 years (2022-12-28)	-96.92%
3 years (2021-12-28)	1.77
5 years (2019-12-27)	0.52

Marizyme financials

Revenue TTM	$364,952
Gross profit TTM	$129,925
Return on assets TTM	-33.89%
Return on equity TTM	-3137.71%
Profit margin	0%
Book value	$-0.07
Market Capitalization more info button	$2.6 million

TTM: trailing 12 months

Marizyme share dividends

We're not expecting Marizyme to pay a dividend over the next 12 months.

You may also wish to consider:

• Switch (SWCH.US) (0.61% forward annual dividend yield)
• KBR (KBR.US) (1.05% forward annual dividend yield)

Have Marizyme's shares ever split?

Marizyme's shares were split on a 1:29 basis on 26 July 2018 . So if you had owned 29 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Marizyme shares – just the quantity. However, indirectly, the new 2800% higher share price could have impacted the market appetite for Marizyme shares which in turn could have impacted Marizyme's share price.

Marizyme share price volatility

Over the last 12 months, Marizyme's shares have ranged in value from as little as $0.02 up to $0.13. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (OTCQB average) beta is 1, while Marizyme's is 0.142. This would suggest that Marizyme's shares are less volatile than average (for this exchange).

To put Marizyme's beta into context you can compare it against those of similar companies.

• Switch (SWCH.US): 0.5923
• Box (BOX.US): 0.852
• KBR (KBR.US): 0.892

Marizyme overview

Marizyme, Inc. , a multi-technology biomedical company, develops and commercializes medical technologies to enhances patients health. It's product portfolio includes DuraGraft, a first-in-class, De Novo granted and CE marked intra-operative vascular graft storage and flushing solution used during coronary artery bypass graft (CABG) surgeries; MATLOC, a point-of-care, lab-on-chip technology platform, developed for quantitative chronic kidney disease assessment; and Krillase, a protein enzyme that acts to break protein bonds and has applications in wound debridement, wound healing, dental care and thrombosi. The company also engages in the development of MAR-FG-001, a fat grafting technology for the use during fat grafting procedures. Marizyme, Inc. was formerly known as GBS Enterprises Incorporated and changed its name to Marizyme, Inc. in March 2018.

Frequently asked questions

What percentage of Marizyme is owned by insiders?
Currently 34.956% of Marizyme shares are held by insiders. When does the fiscal year end for Marizyme?
Marizyme's fiscal year ends in December. Where is Marizyme based?
Marizyme's address is: 555 Heritage Drive, Jupiter, FL, United States, 33458 What is Marizyme's ISIN number?
Marizyme's international securities identification number is: US5703721028